How skin cancer cells evade immune system: study

January 18, 2011 by Marlowe Hood

Scientists have pinpointed a molecular mechanism in mice which helps skin cancer cells confound the animal's immune system, according to a study released Wednesday.

The discovery -- if duplicated in humans -- could one day lead to drug treatments that block this mechanism, and thus the cancer's growth, the study reported.

In experiments on mice, researchers showed for the first time that a protein called interferon-gamma (IFN-gamma) plays a key role in the spread of melanoma, a notoriously aggressive form of resistant to standard chemotherapy.

The same kind of that leads to sunburn caused white blood cells to infiltrate the skin of the mice, explained Glenn Merlino, a scientist at the US National Cancer Institute and the main architect of the study.

The white blood cells, in turn, "can produce IFN-gamma. We believe that IFN-gamma can promote melanoma in our model system, and perhaps in people," he said in an email.

Injecting the mice with antibodies that block IFN-gamma interrupted this signalling process, effectively reducing the risk of UV-induced , the researchers found.

"We are trying to develop inhibitors that are more practical than antibodies, a small molecule, for example," Merlino said.

Ideally, such a treatment would mean that someone exposed to large doses of -- long summers at the beach without protective cream, for example -- could escape the potentially lethal threat of skin cancer.

"But we would never encourage intense sunbathing, even if such a treatment were available," Merlino cautioned.

Cases of cutaneous malignant melanoma are increasing faster than any other type of cancer.

In 2000, over 200,000 cases of melanoma were diagnosed and there were 65,000 melanoma-associated deaths, according to the World Health Organisation (WHO).

The findings, reported in the British-based science journal Nature, could upend assumptions about the relationship between interferon proteins and cancer, the study suggested.

Up to now, interferons were thought to impede the formation of cancer tumours. One in particular, interferon-alpha, has been widely used to treat , both as a first-line drug and an adjutant.

Earlier research has raised doubts as to effectiveness of the treatment, which also has serious side effects.

The highest recorded incidence was in Australia, where the annual rates are 10 and over 20 times the rates in Europe for women and men respectively.

The main risk factors are high exposure to the sun and other UV sources such as sunbeds, along with genetic factors.

The disease is far more common among people with a pale complexion, blue eyes, and red or fair hair.

Related Stories

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

New study reveals breast cancer cells recycle their own ammonia waste as fuel

October 19, 2017
Breast cancer cells recycle ammonia, a waste byproduct of cell metabolism, and use it as a source of nitrogen to fuel tumor growth, report scientists from Harvard Medical School in the journal Science.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

fixer
not rated yet Jan 18, 2011
And does Glenn Merlino know that mice and humans have significantly different immune systems and that using mice to develop immune therapies for humans is usually just a waste of mice?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.